Steve Sweet
Biographic Data
| ID | 10458076 |
|---|---|
| NAME | Steve Sweet |
| GIVEN NAMES | Steve |
| FAMILY NAME | Sweet |
| SIGNATURE | SWEET S |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2010 |
| LATEST PUBLICATION YEAR | 2010 |
| H-INDEX | 0 |
Health and economic impact of rotavirus vaccination in Gavi-eligible countries
Our findings suggest that rotavirus vaccination would be considered a worthwhile investment for improving general development as well as childhood health level in most low-income countries, with a favorable cost-effectiveness profile even under a vaccine price ($1.5-$5.0 per dose) higher than those of traditional childhood vaccines
No prominent works on this page.
Health and economic impact of rotavirus vaccination in Gavi-eligible countries
Our findings suggest that rotavirus vaccination would be considered a worthwhile investment for improving general development as well as childhood health level in most low-income countries, with a favorable cost-effectiveness profile even under a vaccine price ($1.5-$5.0 per dose) higher than those of traditional childhood vaccines
Developing country (1 works) · Diarrhea (1 works) · Disease burden (1 works) · Economic growth (1 works) · Environmental health (1 works) · Hepatitis Viruses Studies and Epidemiology (1 works) · Immunology (1 works) · Medicine (1 works) · Pediatrics (1 works) · Per capita (1 works)